Noah AI: An AI Agent Built for Life Sciences
Exhibitor: SHANGHAI NOAH AI TECHNOLOGY CO., LTD.
Date: 2026-05-22
Booth No.: L426
As AI transforms the way people work, life sciences professionals still face a major gap: most AI tools are not built for the complexity and precision required in biomedical research.
That’s why we built Noah AI Agent — an AI-native assistant designed specifically for biopharma, healthcare, and life science workflows.
Unlike general-purpose AI tools, Noah is built to handle complex professional tasks across literature review, clinical analysis, competitive intelligence, and biomedical research. It can autonomously search trusted medical sources, organize information, analyze data, and generate structured outputs for decision-making.
Built for Biomedical Research Workflows
Noah helps users complete complex research tasks through a single workflow.
Need a disease landscape overview, drug pipeline analysis, clinical trial summary, or competitive intelligence report? Noah can independently retrieve information from trusted biomedical databases, synthesize findings, and generate structured insights in minutes.
Domain-Specific Search for Life Sciences
Noah includes dedicated biomedical search modes designed around professional research needs.
-
Medical Search Mode searches trusted sources including NIH and FDA databases
-
PubMed Mode prioritizes high-quality scientific literature based on relevance and publication quality
-
Agent Mode combines public web results with specialized biomedical datasets covering clinical trials, drugs, patents, and industry intelligence
Rather than simply retrieving information, Noah is designed to understand what matters in biomedical research.
AI-Powered Biomedical Intelligence
Beyond search, Noah helps researchers and industry teams analyze and synthesize complex scientific information at scale.
The platform supports AI-driven comparative analysis across clinical data, competitive landscapes, and industry developments — helping users move from fragmented information to decision-ready insights faster.
Building the Future of AI for Life Sciences
At Noah AI, we believe the next generation of AI systems will go beyond conversational search. AI should help professionals organize knowledge, execute workflows, and accelerate scientific decision-making across research and healthcare.
We are continuing to expand Noah AI’s capabilities across biomedical research, clinical intelligence, and AI-driven scientific workflows.
More Exhibitor's Press Release
- Wallonia exhibits at BIO Asia-Taiwan 2026 for the 3rd consecutive year: showcasing biotech strengths WALLONIA EXPORT-INVESTMENT AGENCY,BELGIUM / 2026-07-21
- MarkerX Unveils AI-Driven Next-Gen Mass Spec Proteomics Platform in Strategic Alliance with Nanomics MARKER X CO., LTD. / 2026-07-15
- Dasher Neuroscience Signs MOU with Norwegian Research Center to Join the Platform Trial HYDRA DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- Dasher-KY Progresses Phase II AI Drug for MSA, Initiating International Licensing Steps DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- TaiMed Launches "Rooting for Love" Charity Campaign in Support of Taiwan Lourdes Association TAIMED BIOLOGICS INC. / 2026-07-15
- Exhibition Preview | Youlin Pharma sincerely invites you to attend BIO Asia-Taiwan 2026 SHANGHAI UNIONCLIN CO,. LTD.(UNIONCLIN) / 2026-07-14
- MicroDoctor Cosmetics Showcases Advanced Dissolving Microneedle Technology at BIO Asia MICRODOCTOR BIOMEDICAL CORPORATION / 2026-07-14
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- TaiMed unveil NextGen TMB-365 CD4-Targeted ADC Platform for HIV Functional Cure at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 -EXOLAB ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - MENARINI ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - DEAKOS ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Taiwan Bio partners with Terumo Blood and Cell Technologies to advance automated Treg manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo BCT and Steminent Collaborate to Advance MSC Late-Stage Clinical Manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo Blood and Cell Technologies Introduces APAC CGT Ecosystem Blueprint TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- [Exhibition News] UVAT to Showcase Breakthrough Technologies at BIO Asia-Taiwan 2026! UVAT TECHNOLOGY CO., LTD. / 2026-07-09
- Painless Decoding, Seamless Tracking: Letting Singular Wings Medical's AI Navigate Your Metabolism. SINGULAR WINGS MEDICAL / 2026-07-08
- TaiMed showcase CD4-Targeted platform breakthroughs and High-Quality CDMO Solutions at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-08
- Lonza Advances Integrated DNA to IND Programs Through Acceleration, De-Risking, and Innovation LONZA / 2026-07-08